Literature DB >> 20010409

Management of chronic leg and knee pain following surgery or trauma related to saphenous nerve and knee neuromata.

Ivica Ducic1, Mark Levin, Ethan E Larson, Ali Al-Attar.   

Abstract

Patients who present with lower extremity pain following surgery or trauma can occasionally have the saphenous nerve as the offending anatomic cause of their pain. Consistent with its anatomic course, the saphenous nerve can be the source of pain that manifests anywhere along its sensory distribution.Patients who presented to the Georgetown Peripheral Nerve Institute with lower extremity pain were evaluated, and those patients whose pain was suspected to be of saphenous nerve origin were offered surgical treatment. The surgical intervention included excision of the neuroma and/or nerve decompression, as clinically indicated. Patients were followed clinically and evaluated for both their pain as well as recovery in their ambulation and quality of life.Forty-two consecutive patients underwent surgery for pain of saphenous nerve origin from 2003 to 2008; 69% of these patients had concomitant surgery on another involved lower extremity peripheral nerve. Follow-up was achieved in 35 patients (83% response rate), with an average follow-up duration of 34.7 months. Using a 10-point pain scale, patients reported their preoperative pain as an 8.0 and their postoperative pain as a 2.37 (P < 0.001). Of the 35 patients, 30 (86%) were able to ambulate at the last follow-up encounter. Patients were asked to report their quality of life on a 10-point scale, and reported a 77% recovery of their baseline quality of life as a result of peripheral nerve surgery performed. Of the 35 patients, 29 reported that the surgery effectively resolved their pain, yielding a success rate of 82.8%.The saphenous nerve can be a source of lower extremity and knee pain following trauma or surgery. Accurate clinical diagnosis followed by surgical intervention can result in clinical resolution in the majority of patients, with improvement in ambulation and quality of life. This study reports the largest series of surgically-corrected saphenous neuropathy in the literature.

Entities:  

Mesh:

Year:  2010        PMID: 20010409     DOI: 10.1097/SAP.0b013e31819b6c9c

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  6 in total

1.  Increased BMP expression in arthrofibrosis after TKA.

Authors:  Tilman Pfitzner; Sven Geissler; Georg Duda; Carsten Perka; Georg Matziolis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-17       Impact factor: 4.342

2.  Infrapatellar saphenous neuralgia after TKA can be improved with ultrasound-guided local treatments.

Authors:  Steven Clendenen; Roy Greengrass; Joseph Whalen; Mary I O'Connor
Journal:  Clin Orthop Relat Res       Date:  2015-01       Impact factor: 4.176

Review 3.  Surgical interventions for the treatment of painful neuroma: a comparative meta-analysis.

Authors:  Louis H Poppler; Rajiv P Parikh; Miles J Bichanich; Kelsey Rebehn; Carrie R Bettlach; Susan E Mackinnon; Amy M Moore
Journal:  Pain       Date:  2018-02       Impact factor: 7.926

4.  Neuroma of the Infrapatellar branch of the saphenous nerve following Total knee Arthroplasty: a case report.

Authors:  Yongbo Xiang; Zeng Li; Peng Yu; Zhibo Zheng; Bin Feng; Xisheng Weng
Journal:  BMC Musculoskelet Disord       Date:  2019-11-13       Impact factor: 2.362

5.  Predictive value of a diagnostic block in focal nerve injury with neuropathic pain when surgery is considered.

Authors:  Martijn J A Malessy; Ralph de Boer; Ildefonso Muñoz Romero; Job L A Eekhof; Erik W van Zwet; Michel Kliot; Albert Dahan; Willem Pondaag
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

6.  Diagnostics of infrapatellar saphenous neuralgia-a reversible cause of chronic anteromedial pain following knee surgery.

Authors:  Schu-Ren Yang; Michael T Hirschmann; Alain Schiffmann; Balazs K Kovacs; Julian Gehweiler; Felix Amsler; Anna Hirschmann
Journal:  Eur Radiol       Date:  2021-08-03       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.